oa Current Allergy & Clinical Immunology - New agents for the treatment of juvenile idiopathic arthritis : review article

Volume 23, Issue 3
  • ISSN : 1609-3607



The medical management of paediatric rheumatic diseases has undergone dramatic changes in the last decades; in particular, more effective use of available classic drugs and the application of newly discovered drugs have been responsible for much of this improvement. The current therapies available to us will undoubtedly change the outcomes for patients with juvenile idiopathic arthritis (JIA) in the coming decades.

In this article, advancing insights in the outcome of JIA are reviewed, and new developments in effective anti-inflammatory and immune therapies for children with severe forms of JIA are discussed.

Loading full text...

Full text loading...


Article metrics loading...


This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error